Work

One-year reductions in cisplatin-related chronic kidney disease (CKD) in patients with head and neck (HNC) cancer treated with avasopasem manganese: A prespecified analysis from the phase 3 ROMAN trial.

Year: 2023

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2023.41.16_suppl.6066

Authors: Bryan G. Allen, Douglas R. Spitz, Kranti A. Mapuskar, Diana Zepeda-Orozco, Robert Alan Beardsley, Eugene Paul Kennedy, Carryn M. Anderson

Institutions: University of Iowa Hospitals and Clinics, Nationwide Children's Hospital, The Ohio State University, Galera Therapeutics, Inc. (United States)

Language: English

Topic: Chemotherapy-induced organ toxicity mitigation

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4379340502

Cites:

Cited by:

Related to: 10